Cited 6 times in

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer

Title
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer
Authors
Sung Gwe Ahn;Joon Jeong;Woo Hee Jung;SoonWon Hong
Issue Date
2015
Journal Title
Journal of Pathology and Translational Medicine
ISSN
2383-7837
Citation
Journal of Pathology and Translational Medicine, Vol.49(5) : 355~363, 2015
Abstract
With the advance in personalized therapeutic strategies in patients with breast cancer, there is an increasing need for biomarker-guided therapy. Although the immunogenicity of breast cancer has not been strongly considered in research or practice, tumor-infiltrating lymphocytes (TILs) are emerging as biomarkers mediating tumor response to treatments. Earlier studies have provided evidence that the level of TILs has prognostic value and the potential for predictive value, particularly in triple-negative and human epidermal growth factor receptor 2–positive breast cancer. Moreover, the level of TILs has been associated with treatment outcome in patients undergoing neoadjuvant chemotherapy. To date, no standardized methodology for measuring TILs has been established. In this article, we review current issues and clinical evidence for the use of TILs in breast cancer.
URI

http://ir.ymlib.yonsei.ac.kr/handle/22282913/141184
DOI
10.4132/jptm.2015.07.29
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Pathology
1. 연구논문 > 1. College of Medicine > Dept. of Surgery
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
T201503593.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse